Dr. Moriya Tsuji – Using proteomics to enable the adaptive and innate immune response in vaccines against COVID-19

A fireside chat with IsoPlexis user Dr. Moryia Tsuji from Columbia

[wpbb post:title]
Moriya Tsuji, MD, PhD, Professor of Medicine at Aaron Diamond AIDS Research Center, Columbia University
  • Using more predictive single cell proteomics in mouse models to understand correlative T cell potency in infectious disease vaccines

  • Understanding of more predictive T cell potency in mouse models important for understanding vaccine development

  • The challenges in pre-clinical vaccine development today that can be overcome by having potency tools and better ways to characterize human immune response

2020-09-21T01:38:33-04:00